Neonatology Pioneer Andy Whitelaw Dies Aged 79
Professor Andy Whitelaw, whose groundbreaking 'therapeutic cooling' and brain clot treatments saved countless premature babies, has died. Read about his life and legacy.
Professor Andy Whitelaw, whose groundbreaking 'therapeutic cooling' and brain clot treatments saved countless premature babies, has died. Read about his life and legacy.
Adana Omágua Kambeba, the first Kambeba doctor, combines her medical degree with shamanic healing. Discover her mission to integrate Indigenous knowledge with science.
Little Bertie Melly, born at 24 weeks with a serious bowel condition, is finally home in Bromley for his first Christmas after over 500 days in hospital. Read his family's remarkable story of hope.
The World Health Organization launches a decade-long strategy to scientifically study and integrate proven traditional remedies into global healthcare. Discover the potential.
The Guardian has issued clarifications regarding a report on A&E waiting times and a story on international climate aid. Read the full details of the corrections here.
The family of Adriana Smith, kept on life support due to Georgia's heartbeat law, share a heartbreaking update as her son, born prematurely, is still too ill to come home for the holidays.
Hyperbaric oxygen therapy is FDA-approved for only 13 conditions, yet some clinics market it for over 100. Experts warn of deadly risks and call for urgent regulation.
Discover how ancient Indigenous food wisdom offers solutions to modern health and environmental crises. Learn why food sovereignty is key to our collective future.
Wellness influencers are drinking methylene blue dye despite serious health risks. Learn why this textile dye is causing concern among medical experts and poison centres.
A groundbreaking trial in Kenya is testing repurposed antibiotics to treat neonatal sepsis, a deadly infection killing 800,000 newborns annually. Discover how this research could transform global treatment guidelines.
Three-year-old Oliver Chu shows dramatic improvement after groundbreaking gene therapy for Hunter syndrome at Manchester hospital. A potential alternative to lifelong treatment.
A revolutionary approach to neonatal abstinence syndrome treats mothers and infants together, achieving 95% recovery rates while challenging traditional foster care outcomes.
Dr Stephen Dawson, who witnessed London's Aids crisis in the 1980s, transformed sexual healthcare in Slough. Read his remarkable story from urology to film-making.
Princess Beatrice reveals the loneliness of premature birth while supporting Borne charity's research campaign. Join the conversation on maternal health support.
The UK government accelerates its plan to replace animal testing with advanced alternatives like 'organs-on-chips' and 3D bioprinting. Discover the timeline and the science behind this ethical shift.
Explore the science behind PEMF therapy mats. Experts weigh in on their potential for pain relief versus evidence-based treatments for chronic conditions in the UK.
UK authorities warn of sophisticated fake weight-loss drugs manufactured by organised crime. Learn how to spot counterfeit products and protect your health.
The CEO of pharmaceutical giant AstraZeneca warns that UK patients may be limited to generic medicines unless the NHS increases what it pays for innovative new treatments, raising concerns about healthcare quality and medical research funding.
Groundbreaking NHS research exposes stark racial disparities in neonatal care outcomes, with Black infants facing significantly higher mortality rates despite medical advances.
Health authorities issue critical safety alert about prescription medication storage as temperatures rise across the UK
Groundbreaking research reveals how museums, galleries and cultural experiences are being prescribed by doctors to treat everything from chronic pain to mental health conditions, transforming healthcare in Britain.
A leading sports injury expert breaks down Alexander Isak's latest fitness concern and what it means for Liverpool's Premier League campaign.
A critical pricing dispute between the UK government and pharmaceutical companies threatens patient access to vital medicines, with industry leaders warning of treatment delays and reduced NHS access to new drugs.